布利祖马布和尼沃卢马布的分子养殖
Michael C Stark1, Anna M Joubert1, Michelle H Visagie1
1Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Private Bag X323, Pretoria 0031, South Africa.
International journal of molecular sciences
|June 28, 2023
概括
分子农业提供了一个低成本,可扩展的解决方案,用于生产免疫检查点抑制剂 (ICI),如pembrolizumab和nivolumab. 这种基于植物的生物制造方法可以改善低收入国家的这些重要癌症治疗方法的可用性.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 在瘤学瘤学.
背景情况:
- 免疫检查点抑制剂 (ICI) 通过抵消瘤细胞的免疫抑制来对抗癌症.
- PD-1/PD-L1通路对于瘤免疫逃避至关重要,抑制T细胞功能.
- 目前的PD-1/PD-L1抑制剂,布罗利祖马布和尼沃卢马布,价格昂贵,在LMIC中无法获得.
研究的目的:
- 探索分子农业作为单克隆抗体 (mAbs) 具有成本效益的生物制造平台.
- 解决低收入和中等收入国家 (LMICs) 基本癌症免疫疗法的可访问性限制.
主要方法:
- 使用植物作为生物反应器生产针对PD-1/PD-L1免疫检查点的mAbs.
- 评估分子农业在快速,可扩展和低成本的mAb生成方面的潜力.
主要成果:
- 分子农业提供了一个可行的策略,用于生产治疗 mAbs.
- 该平台显示了在ICI制造业显著降低成本的潜力.
- 这种方法是快速的,可扩展的,适合在LMICs实施.
结论:
- 分子农业可以降低PD-1/PD-L1抑制剂的成本,提高全球可访问性.
- 实施基于植物的mAb生产可以降低LMICs的癌症死亡率.
- 这种生物制造创新有望为全球平等的癌症治疗提供希望.
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Vaccines
433
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433
Hybridoma Technology
15.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.0K


